for those running out of options--the latest--from San Antonio

[Lani]

the doxyrubicin is indeed adriamycin by another name
cyclophosphamide is the C in AC

But the point of this study was the addition of hydralazine and valproate--they just had to add it to AC as all clinical trials must add to what is felt to be an appropriate effective treatment to see if the addition is better. Just as they did not test herceptin by itself, but rather how much improvement there was in survival, time to progression, etc by adding herceptin to chemotherapy.